Shannon L Coe, SLP in Albany, IN - Speech-Language Pathologist

Shannon L Coe, SLP is a Speech-language Pathologist based in Albany, Indiana. Shannon L Coe is licensed to practice in Indiana (license number 46001902A) and her current practice location is 910 W Walnut St, Albany, Indiana. She can be reached at her office (for appointments etc.) via phone at (765) 789-4423.

NPI number for Shannon L Coe is 1144475344 and her current mailing address is 910 W Walnut St, Albany, Indiana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1144475344.

Contact Information

	Shannon L Coe, SLP
	910 W Walnut St, Albany, IN 47320-1530
	(765) 789-4423
	(765) 789-4433

Healthcare Provider's Profile

Full Name	Shannon L Coe
Gender	Female
Speciality	Speech-language Pathologist
Location	910 W Walnut St, Albany, Indiana
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1144475344
Provider Enumeration Date: 12/02/2008
Last Update Date: 12/02/2008

Medical Identifiers

Medical identifiers for Shannon L Coe such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1144475344	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	46001902A (Indiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Shannon L Coe is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Shannon L Coe, SLP 910 W Walnut St, Albany, IN 47320-1530 Ph: (765) 789-4423	Shannon L Coe, SLP 910 W Walnut St, Albany, IN 47320-1530 Ph: (765) 789-4423

News Archive

Drug for children with sickle cell anemia reduces hospitalizations and treatment costs

A drug proven effective for treatment of adults and children with sickle cell anemia reduced hospitalizations and cut annual estimated medical costs by 21 percent for affected infants and toddlers, according to an analysis led by St. Jude Children's Research Hospital. The report appears today in the advance online edition of the journal Pediatrics.

Johns Hopkins doctoral program graduate explores ways to control infectious diseases

Her passport is stamped with exotic locations: Myanmar, Tibet, South Africa, Vietnam, and Cambodia, as well as Baltimore, MD. But, when Carrie Tudor, PhD, MPH, RN, looks at it, she sees global battlefields in the fight against infectious disease. Her weapons: immunizations, programs to curb tuberculosis and HIV transmission, and a drive to carry on a rich tradition of public health nursing research.

Fentanyl transdermal patch is an effective way to control pain in children

A new study says using a transdermal patch to deliver the opioid fentanyl is an effective way to control pain in children

NUS scientists find new mechanism to inhibit breast cancer metastasis

A team of researchers from the Cancer Science Institute of Singapore at the National University of Singapore has found that controlling the levels of the TIP60 protein, which is a tumour suppressor, could potentially prevent the spread of breast cancer cells.

PD linked to increased cancer risk in Asian population

A Taiwanese population-based cohort study reports an increased risk of most cancers in patients with Parkinson's disease, contrasting with findings in Western populations.

Shannon L Coe, SLP - Speech-Language Pathologist in Albany, IN